发明名称 |
GENETIC PROFILING AND HEALTHCARE MANAGEMENT: ADME (ABSORPTION, DISTRIBUTION, METABOLISM & ELIMINATION) & TOXICOLOGY PATENT APPLICATION |
摘要 |
According to the invention, the number of genes and their configurations (mutations and polymorphisms) needed to be identified in order to provide critical clinical information concerning individual prognosis is considerably less than the 100,000 thought to comprise the human genome. The identification of the identity of the core group of genes enables the invention of a design for genetic profiling technologies which comprises of the identification of the core group of genes and their sequence variants required to provide a broad base of clinical prognostic information " genostics ". The invention is meant to radically enhance the ability of clinicians, healthcare professionals and other parties to plan and manage healthcare provision and the targeting of appropriate healthcare resources to those deemed most in need. |
申请公布号 |
WO2004033722(A2) |
申请公布日期 |
2004.04.22 |
申请号 |
WO2003GB04051 |
申请日期 |
2003.09.23 |
申请人 |
SCIONA LIMITED;ROBERTS, GARETH, WYN;GRIMALDI, KEITH |
发明人 |
ROBERTS, GARETH, WYN;GRIMALDI, KEITH |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|